NCT02479854View on ClinicalTrials.gov

Bioequivalence Study of Montelukast From Asmakast 5mg Chewable Tab.(Sandoz, Egypt) & Singulair 5mg Chewable Tab.(Merck)

PHASE1CompletedINTERVENTIONAL

Enrollment

24

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

April 30, 2014

Study Completion Date

April 30, 2014

Conditions

Healthy

Interventions

DRUG

Asmakast

1 chewable tablet contains 5 mg montelukast

DRUG

Singulair

1 chewable tablet contains 5 mg montelukast

Trial Locations (1)

Unknown

Genuine Research Center GRC, Cairo

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Sandoz

INDUSTRY

lead

Genuine Research Center, Egypt

INDUSTRY